HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vous Vitamin Adds Pregnancy Products To Line Formulated On Customers’ Needs

Executive Summary

Vous Vitamin rolls out a pre- and post-natal multivitamin line that factors in diet, lifestyle and pre-pregnancy health. Founders are doctors who say their personalized multivitamins differ from most other customized vitamin lines by delivering nutrition in two pills.

You may also be interested in...



Nestle's Atrium Adds LivingMatrix As New Cog In Personalized Health Strategy

Atrium expects to scale its nutrition personalization services by integrating LivingMatrix with its PureGenomics platform, which combines educational tools, protocols and core products with a practitioner website application to help identify and address single nucleotide polymorphisms.

Wellness Business Roundup: VSI Gets Personal, GNC Gets Brazil Partner, Brightstar Adds Capstone, US Firm Has German CBD Partner

Vitamin Shoppe launches Only Me personalized program/subscription service; GNC expands into “key” target market with Brazilian retail operator; Brightstar to acquire Capstone from H.I.G.; Columbia Care partners with Germany's Moeller on CBD-infused products.

Wellness Industry News: Acting FDA Commissioner Named, Thorne Test Line Grows, Nitrosigine In Revel Energy, More

NCI's Sharpless named acting FDA head; Mannatech trims loss as costs grow; Nilo drinks to avoiding hangovers; Daoust leads Soylent Nutrition development, innovation; Viactiv in taller, narrower package; Revel Energy made with Nitrosigine; and Thorne has at-home tests for additional concerns.

Related Content

Topics

UsernamePublicRestriction

Register

RS149608

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel